Both retatrutide and tirzepatide are GLP-1 class medications developed by Eli Lilly, but they differ in receptor mechanism, FDA approval status, weight loss trial results, and availability
It's a no-win situation unless you break this vicious circle and supplement the much-needed vitamins
There is still a need for more research to understand the long-term effects of GLP-1 and GIP supplements
Direct-to-consumer telehealth platforms have built entire business models around prescribing and shipping these medications, often bundling in coaching, lab work, and follow-up visits into a single subscription
However, there are concerns that greater weight loss could have a negative impact on muscle mass, especially in more susceptible patients
Without enough B12, people may feel tired and listless, or suffer from headaches